2020 Update Regarding the Importation of Prescription Drugs: Pathway to Importation from Canada Initiated, Risk Remains

By Ronald Friedman, Esq., Karr Tuttle Campbell, Seattle, WA

Over the past two years there has been considerable political interest in finding a way to lower the price of prescription drugs to U.S. residents.  This interest has been expressed by both Houses of Congress2 and by the President.3  Numerous bills have been advanced by both chambers and both political parties, suggesting various mechanisms to achieve price reduction. These include imposing price limits on drugs for patients where the payor is the federal government, and tying U.S. drug prices to an international index of the average price of the drug in multiple foreign countries.4  Each of these bills faces opposition, and it is hard to predict passage of any one.  

Premium Content For:
  • Health Law Section
Join - Now